Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Retailer Training Crucial To Keeping Supplement Claims Compliant

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement manufacturers bear the burden of ensuring businesses selling their products comply with claims regulations, experts say

You may also be interested in...



U.K. Supplement Retailer’s “Suitable” Customer Advice Likely Unsuitable In U.S.

Holland & Barrett ads clarify store clerks’ advice “would be in relation to nutrition and supplements, rather than general or individual health advice,” the UK advertising regulator says. While some US retailers train staff about supplement claims, they do not have as much room for advising customers as the UK agency allows in its ruling on a challenge.

U.K. Supplement Retailer’s “Suitable” Customer Advice Likely Unsuitable In U.S.

Holland & Barrett ads clarify store clerks’ advice “would be in relation to nutrition and supplements, rather than general or individual health advice,” the UK advertising regulator says. While some US retailers train staff about supplement claims, they do not have as much room for advising customers as the UK agency allows in its ruling on a challenge.

InterHealth Responsible For Zychrome Claims By Manufacturers – NAD

NAD recommends InterHealth discontinue superiority claims comparing its Zychrome chromium dinicocysteinate ingredient to Nutrition 21’s chromium picolinate product, Chromax. The decision tracks FTC’s position of holding branded ingredient suppliers responsible for claims made by their customers.

Related Content

Topics

UsernamePublicRestriction

Register

PS104437

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel